An Chen

658 total citations
31 papers, 491 citations indexed

About

An Chen is a scholar working on Molecular Biology, Immunology and Electrical and Electronic Engineering. According to data from OpenAlex, An Chen has authored 31 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Electrical and Electronic Engineering. Recurrent topics in An Chen's work include Advanced biosensing and bioanalysis techniques (5 papers), RNA modifications and cancer (4 papers) and Cancer Mechanisms and Therapy (3 papers). An Chen is often cited by papers focused on Advanced biosensing and bioanalysis techniques (5 papers), RNA modifications and cancer (4 papers) and Cancer Mechanisms and Therapy (3 papers). An Chen collaborates with scholars based in China, United States and Canada. An Chen's co-authors include Chuanmin Hu, Weijing Yi, Wenbin Liang, Ruo Yuan, Shuhui Li, Zhujun Zhang, Sharlene Hesse‐Biber, Beixue Gao, Yaqin Chai and Ying Zhuo and has published in prestigious journals such as Molecular and Cellular Biology, Journal of Virology and The FASEB Journal.

In The Last Decade

An Chen

30 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
An Chen China 15 277 115 108 63 50 31 491
Salomón Hernández-Gutiérrez Mexico 11 266 1.0× 142 1.2× 101 0.9× 43 0.7× 31 0.6× 28 590
Qunfeng Yao China 14 368 1.3× 183 1.6× 72 0.7× 101 1.6× 47 0.9× 21 551
Huinan Chen China 14 336 1.2× 149 1.3× 101 0.9× 111 1.8× 20 0.4× 22 505
Mohammad Ali Zaimy Iran 9 186 0.7× 73 0.6× 55 0.5× 54 0.9× 24 0.5× 11 409
Hanwen Zhang China 11 629 2.3× 94 0.8× 65 0.6× 102 1.6× 115 2.3× 19 880
Jiexia Chen China 9 204 0.7× 55 0.5× 43 0.4× 43 0.7× 52 1.0× 24 329
Xin Nie China 12 258 0.9× 88 0.8× 46 0.4× 97 1.5× 29 0.6× 25 512
Bin Du China 11 294 1.1× 80 0.7× 59 0.5× 38 0.6× 21 0.4× 36 504
Pu Liao China 10 397 1.4× 177 1.5× 40 0.4× 156 2.5× 32 0.6× 16 631
Yanwei Lu China 17 624 2.3× 189 1.6× 104 1.0× 80 1.3× 44 0.9× 47 945

Countries citing papers authored by An Chen

Since Specialization
Citations

This map shows the geographic impact of An Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by An Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites An Chen more than expected).

Fields of papers citing papers by An Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by An Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by An Chen. The network helps show where An Chen may publish in the future.

Co-authorship network of co-authors of An Chen

This figure shows the co-authorship network connecting the top 25 collaborators of An Chen. A scholar is included among the top collaborators of An Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with An Chen. An Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Ming, Dong Liu, Lingxi Chen, et al.. (2025). Deacetylation of ANXA2 by SIRT2 desensitizes hepatocellular carcinoma cells to donafenib via promoting protective autophagy. Cell Death and Differentiation. 32(9). 1630–1647. 1 indexed citations
2.
3.
Fu, Mingwei, Zirong Lan, Yuanzhi Ye, et al.. (2025). The metabolite alpha-ketoglutarate inhibits vascular calcification partially through modulation of the TET2/NLRP3 inflammasome signaling pathway. Kidney International. 108(2). 233–252. 2 indexed citations
4.
Liu, Yiman, Meng Jia, Jia Liu, et al.. (2025). NLRP3 inflammasome in acute lung injury: Cumulative evidence for traditional Chinese medicine and natural products. Chinese Herbal Medicines. 17(4). 703–719. 2 indexed citations
5.
Zeng, Rong, Meng He, Xufang Dai, et al.. (2024). Inhibition of KIAA1429/HK1 axis enhances the sensitivity of liver cancer cells to sorafenib by regulating the Warburg effect. Biochemical Pharmacology. 227. 116419–116419. 6 indexed citations
6.
Yang, Mingzhen, Meng He, Xiang Li, et al.. (2024). KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells. Cancer Letters. 584. 216598–216598. 17 indexed citations
7.
He, Meng, Dong Liu, Xufang Dai, et al.. (2023). Dihydroergotamine mesylate enhances the anti-tumor effect of sorafenib in liver cancer cells. Biochemical Pharmacology. 211. 115538–115538. 5 indexed citations
8.
Xiao, Hanxi, Yaran Wu, Dongjing Yan, et al.. (2023). CircPHKB decreases the sensitivity of liver cancer cells to sorafenib via miR-1234-3p/CYP2W1 axis. Genomics. 116(1). 110764–110764. 2 indexed citations
9.
Xu, Jia, An Chen, & Ting Cai. (2022). Polymorphism of Purpurin and Low-level Detection of the Noncentrosymmetric form by Second Harmonic Generation Microscopy. Journal of Pharmaceutical Sciences. 112(1). 282–289. 1 indexed citations
10.
Zhang, Yang, Jinhua Mao, Jincheng Mao, et al.. (2022). Towards sustainable oil/gas fracking by reusing its process water: A review on fundamentals, challenges, and opportunities. Journal of Petroleum Science and Engineering. 213. 110422–110422. 25 indexed citations
11.
Yan, Xiaojing, Xufang Dai, Chen Huang, et al.. (2021). Dichloroacetate enhances the anti-tumor effect of sorafenib via modulating the ROS-JNK-Mcl-1 pathway in liver cancer cells. Experimental Cell Research. 406(1). 112755–112755. 13 indexed citations
12.
Chen, Sha, Songtao Yu, Ming He, et al.. (2021). Synthesis of Mitochondria-Anchored Nitroimidazoles with a Versatile NIR Fluorophore for Hypoxic Tumor-Targeting Imaging and Chemoradiotherapy. Journal of Medicinal Chemistry. 64(6). 3381–3391. 36 indexed citations
13.
Dong, Yuan, et al.. (2019). Generation of a Monoclonal Antibody against D-Dimer Using HTS-Based LiCA. SLAS DISCOVERY. 25(3). 310–319. 4 indexed citations
14.
Hesse‐Biber, Sharlene & An Chen. (2015). Within-Gender Differences in Medical Decision Making Among Male Carriers of the BRCA Genetic Mutation for Hereditary Breast Cancer. American Journal of Men s Health. 11(5). 1444–1459. 22 indexed citations
15.
Liang, Wenbin, Yan Li, Bo Zhang, et al.. (2011). A novel microfluidic immunoassay system based on electrochemical immunosensors: An application for the detection of NT-proBNP in whole blood. Biosensors and Bioelectronics. 31(1). 480–485. 56 indexed citations
16.
Yi, Weijing, Wenbin Liang, Shuhui Li, et al.. (2011). Application of a Fab fragment of monoclonal antibody specific to N-terminal pro-brain natriuretic peptide for the detection based on regeneration-free electrochemical immunosensor. Biotechnology Letters. 33(8). 1539–1543. 19 indexed citations
17.
Zhuo, Ying, Weijing Yi, Ruo Yuan, et al.. (2010). Ultrasensitive electrochemical strategy for NT-proBNP detection with gold nanochains and horseradish peroxidase complex amplification. Biosensors and Bioelectronics. 26(5). 2188–2193. 65 indexed citations
18.
Liang, Wenbin, Weijing Yi, Shuhui Li, et al.. (2009). A novel, label-free immunosensor for the detection of α-fetoprotein using functionalised gold nanoparticles. Clinical Biochemistry. 42(15). 1524–1530. 41 indexed citations
19.
Chen, An. (2004). Isolation and structural identification of insecticidal activities from Ligusticum sinense Oliv.. Xibei Nong-Lin Keji Daxue xuebao. Ziran kexue ban. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Salomón Hernández-Gutiérrez Breakdown of academic impact, for papers by Qunfeng Yao Breakdown of academic impact, for papers by Huinan Chen Breakdown of academic impact, for papers by Mohammad Ali Zaimy Breakdown of academic impact, for papers by Hanwen Zhang Breakdown of academic impact, for papers by Jiexia Chen Breakdown of academic impact, for papers by Xin Nie Breakdown of academic impact, for papers by Bin Du Breakdown of academic impact, for papers by Pu Liao Breakdown of academic impact, for papers by Yanwei Lu
Rankless by CCL
2026